{"data":{"id":"sw_8337bec92c6fc895301b","slug":"kenvue-s-dividend-hike-pushes-payout-ratio-past-107-of-earnings","title":"Kenvue's Dividend Hike Pushes Payout Ratio Past 107% of Earnings","subheadline":"The consumer-health spinoff's latest quarterly increase leaves its dividend outlay above GAAP earnings, a gap investors are watching closely.","summary":"Kenvue's payout ratio has climbed to 107.55% of GAAP earnings after a recent dividend increase, meaning the company is distributing more than it currently reports in profit, even as its yield has eased on a rising share price.","body":"Kenvue Inc., the consumer-health company spun off from Johnson & Johnson in 2022, is paying out more in dividends than it currently earns on a GAAP basis, with its payout ratio sitting at 107.55%, according to dividend-tracking data. The figure follows a recent increase in the company's quarterly dividend to $0.21 per share, a move that first stood out in data tracked on Dividendly, a Madison Labs research site. A payout ratio above 100% means the company's dividend outlay exceeds its per-share GAAP earnings for the period measured, a mathematical condition rather than a prediction about what happens next.\n\nThe mechanics behind the ratio are straightforward: Kenvue's board raised the quarterly payment even as reported earnings have not kept pace, pushing the share of profit committed to dividends past the full-coverage line. Kenvue markets a portfolio of well-known consumer brands (including Tylenol, Listerine, Neutrogena, Band-Aid and Zyrtec) spread across its Self Care, Skin Health and Beauty, and Essential Health divisions. The company, headquartered in Skillman, New Jersey, has been paying dividends for two years since separating from Johnson & Johnson, and has raised the payout in two consecutive annual increases, according to the same dividend data.\n\nFor income-focused investors, a payout ratio above 100% is one of several inputs used to gauge how durable a dividend might be, alongside cash-flow coverage, balance-sheet flexibility and earnings trends: none of which are captured by the ratio alone. GAAP payout ratios can be distorted by one-time charges, amortization from a corporate spinoff, or other non-cash items that reduce reported earnings without affecting the cash actually available to fund a dividend. Kenvue's separation from Johnson & Johnson in 2022 and subsequent public listing mean its earnings history is short, and the dividend-tracking data notes that the company has only two years of payment history on record, well short of the 20-year window some scoring frameworks use to judge whether a payout has been tested across a full economic cycle.\n\nKenvue currently carries a dividend yield of 4.38%, based on the latest annualized rate against a share price of $19.17 as of August 30. That yield has actually declined over the past roughly 90 days, falling from 4.92% to 4.38%, and the dividend-tracking data attributes almost all of that move, roughly 0.59 percentage points, to the stock's price rising from $16.88 to $19.17, versus a much smaller 0.05 percentage point contribution from the dividend rate itself. In other words, the yield compression reflects share-price appreciation rather than any change in the payout, a distinction the data explicitly flags because a yield that falls on rising price is a different signal than one that falls because a company cut its dividend. Kenvue shares have traded between $14.11 and $20.78 over the past 52 weeks, and the stock closed the most recent session down $0.03, or 0.16%, on volume of nearly 11.9 million shares, giving the company a market capitalization of roughly $32.95 billion.\n\nThe payout-ratio question sits within a broader market backdrop where dividend durability has been a recurring theme for income investors, with names like Procter & Gamble, Genuine Parts and S&P Global drawing attention this week for their own yield and growth profiles, according to financial-media coverage circulating alongside the Kenvue data. Equity markets more broadly were mixed to lower in the same session, with technology-linked names including Oracle, Palo Alto Networks and Applied Materials each down more than 3% intraday, underscoring that sector-specific and company-specific dividend questions like Kenvue's are unfolding against a choppier tape rather than in isolation.\n\nLooking ahead, investors tracking Kenvue's dividend will likely watch whether the company's earnings recover enough to bring the payout ratio back under 100%, whether the board maintains its recent pace of annual increases, and how the stock's valuation, currently near the upper half of its 52-week range, continues to influence the reported yield independent of any change in the dividend itself. Kenvue's next ex-dividend date and payment will offer the first concrete data points on whether the pattern of gradual increases continues, though no assurance exists as to future dividend actions, and any decision by the board rests on factors including earnings, cash flow and capital-allocation priorities that have not been detailed in the available data.","source":{"name":"Dividendly","slug":"dividendly"},"category":"Dividends","article_type":"News","license":"Free to republish, in full or in part, with attribution to SourceWire and a link to the original article. No fees, registration, or permission required.","quality_score":83,"human_reviewed":false,"original_url":"https://dividendly.ai/stock/KVUE","featured_image":null,"published_at":"2026-09-02T11:30:00.821290+00:00","updated_at":"2026-09-02T11:30:00.821290+00:00","is_demo":false,"attribution":"Via SourceWire. Discovered via Dividendly.","attribution_html":"Via SourceWire. Discovered via Dividendly."},"meta":{"demo_data":false}}